I agree that this site is using cookies. You can find further informations here.
X
DENDA, Y.
63  results:
Search for persons X
?
1

Postoperative adjuvant therapy for patients with loco-regio..:

Yanamoto, S. ; Denda, Y. ; Ota, Y....
International Journal of Oral and Maxillofacial Surgery.  49 (2020)  7 - p. 848-853 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Omnidirectional Audio-Visual Talker Localization Based on D..:

DENDA, Y. ; NISHIURA, T. ; YAMASHITA, Y.
IEICE Transactions on Information and Systems.  E91-D (2008)  3 - p. 598-606 , 2008
Link: https://doi.org/10.1093/..
 
?
3

Robust Talker Direction Estimation Based on Weighted CSP An..:

DENDA, Y.
IEICE Transactions on Information and Systems.  E89-D (2006)  3 - p. 1050-1057 , 2006
Link: https://doi.org/10.1093/..
 
?
4

Microstructural evolution in ceramics and grapmte under cas..:

Kinoshita, C. ; Isobe, Y. ; Abe, H...
Journal of Nuclear Materials.  206 (1993)  2-3 - p. 341-352 , 1993
Link: https://doi.org/10.1016/..
 
?
5

Association of PD-L1 and PD-L2 expression and tumor-infiltr..:

Imai, M. ; Nakamura, Y. ; Denda, T....
ESMO Gastrointestinal Oncology.  2 (2023)  - p. 100008 , 2023
Link: https://doi.org/10.1016/..
 
?
6

A phase II study to explore biomarkers for the use of mFOLF..:

Okamoto, W. ; Sakai, K. ; Makiyama, A....
ESMO Open.  7 (2022)  6 - p. 100592 , 2022
Link: https://doi.org/10.1016/..
 
?
7

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or Cape..:

Yamada, Y. ; Denda, T. ; Gamoh, M....
Annals of Oncology.  29 (2018)  3 - p. 624-631 , 2018
Link: https://doi.org/10.1093/..
 
?
8

2168 Predictive biomarker analysis of early tumor shrinkage..:

Tsuji, Y. ; Yamazaki, K. ; Oba, M. Saito...
European Journal of Cancer.  51 (2015)  - p. S389-S390 , 2015
Link: https://doi.org/10.1016/..
 
?
9

2151 Timing of adverse events (AEs) in the Phase 3 RECOURSE..:

Shinozaki, E. ; Laurent, S. ; Gravalos, C....
European Journal of Cancer.  51 (2015)  - p. S383-S384 , 2015
Link: https://doi.org/10.1016/..
 
?
10

FOLFIRI plus bevacizumab as second-line therapy in patients..:

Iwamoto, S. ; Takahashi, T. ; Tamagawa, H....
Annals of Oncology.  26 (2015)  7 - p. 1427-1433 , 2015
Link: https://doi.org/10.1093/..
 
?
11

2150 Low rates of hospitalizations with TAS-102 in the Euro..:

Falcone, A. ; Garcia-Carbonero, R. ; Tabernero, J....
European Journal of Cancer.  51 (2015)  - p. S383 , 2015
Link: https://doi.org/10.1016/..
 
?
12

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as F..:

Nishina, T. ; Takano, Y. ; Denda, T....
Japanese Journal of Clinical Oncology.  43 (2013)  11 - p. 1080-1086 , 2013
Link: https://doi.org/10.1093/..
 
?
13

Randomized Phase III Study of 5-Fluorouracil Continuous Inf..:

Shirao, K. ; Boku, N. ; Yamada, Y....
Japanese Journal of Clinical Oncology.  43 (2013)  10 - p. 972-980 , 2013
Link: https://doi.org/10.1093/..
 
?
14

Anaemia in CKD 1-5:

Hirata, M. ; Tashiro, Y. ; Aizawa, K....
Nephrology Dialysis Transplantation.  28 (2013)  suppl 1 - p. i358-i365 , 2013
Link: https://doi.org/10.1093/..
 
?
15

Field survey of depressive and manic symptoms and autistic ..:

Inoue, T. ; Denda, K. ; Sato, Y..
Neuropsychiatrie de l'Enfance et de l'Adolescence.  60 (2012)  5 - p. S166 , 2012
Link: https://doi.org/10.1016/..
 
1-15